NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 1, 2024 $80.07 -2.35% $79.50 V 99.28% 4
Apr 1, 2024 $78.25 -4.57% $79.50 V 98.43% 1
JS JS Pro
Apr 1, 2024 $79.33 -3.26% $79.50 V 99.79% 6
JS JS Pro
Mar 26, 2024 $69.22 +0.04% $80.83 V 85.64% 1
Mar 26, 2024 $67.40 -2.59% $80.83 X 83.38% 0
Mar 26, 2024 $66.32 -4.15% $80.83 X 82.05% 0
Mar 12, 2024 $66.98 +5.58% $67.10 V 99.82% 6
Mar 12, 2024 $65.65 +3.48% $67.10 V 97.84% 1
Mar 12, 2024 Bullish $67.10 V 1
AlexVel AlexVel Pro
Mar 8, 2024 $75.12 +1.51% $71.78 X 95.35% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE